Atlas Trials

Safety and Efficacy of Radiotherapy Combined with Immunotherapy for Advanced Malignant Tumors.

Clinical trial NCT06173219 · RECRUITING

Trial details

NCT number
NCT06173219
Sponsor
China-Japan Friendship Hospital
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Advanced Solid Tumor
Start date
2025-08-01
Primary completion
2026-07-31
Enrollment
38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.